William L. Dahut

Oncology

10 Center Dr Rm 12C103
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Journal: Journal for immunotherapy of cancer

Published: March 13, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 26, 2026

Integrative dual ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumor transcription and resistance phenotypes in metastatic prostate cancer.

Integrative dual ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumor transcription and resistance phenotypes in metastatic prostate cancer.

Journal: Research square

Published: February 12, 2026

Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkers.

Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkers.

Journal: Cancer

Published: October 20, 2025

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

Journal: CA: a cancer journal for clinicians

Published: October 10, 2025

Consensus-built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative.

Consensus-built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative.

Journal: Cancer

Published: August 09, 2025

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications.

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications.

Journal: bioRxiv : the preprint server for biology

Published: June 26, 2025

Prostate cancer statistics, 2025.

Prostate cancer statistics, 2025.

Journal: CA: a cancer journal for clinicians

Published: May 20, 2025

Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States.

Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 20, 2025

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.

Journal: Oncotarget

Published: March 12, 2025

Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

Journal: Journal for immunotherapy of cancer

Published: February 26, 2025

Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.

Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition.

Journal: The Journal of clinical investigation

Published: December 04, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026